Cargando…

Probing Cocaine-Antibody Interactions in Buffer and Human Serum

BACKGROUND: Despite progress in cocaine immunotherapy, the kinetic and thermodynamic properties of antibodies which bind to cocaine and its metabolites are not well understood. It is also not clear how the interactions between them differ in a complex matrix such as the serum present in the human bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishnan, Muthu, Alves De Melo, Fernando, Kinsey, Berma M., Ladbury, John E., Kosten, Thomas R., Orson, Frank M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409241/
https://www.ncbi.nlm.nih.gov/pubmed/22859949
http://dx.doi.org/10.1371/journal.pone.0040518
_version_ 1782239567493988352
author Ramakrishnan, Muthu
Alves De Melo, Fernando
Kinsey, Berma M.
Ladbury, John E.
Kosten, Thomas R.
Orson, Frank M.
author_facet Ramakrishnan, Muthu
Alves De Melo, Fernando
Kinsey, Berma M.
Ladbury, John E.
Kosten, Thomas R.
Orson, Frank M.
author_sort Ramakrishnan, Muthu
collection PubMed
description BACKGROUND: Despite progress in cocaine immunotherapy, the kinetic and thermodynamic properties of antibodies which bind to cocaine and its metabolites are not well understood. It is also not clear how the interactions between them differ in a complex matrix such as the serum present in the human body. In the present study, we have used microscale thermophoresis (MST), isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) we have evaluated the affinity properties of a representative mouse monoclonal (mAb08) as well as those of polyclonal antibodies purified from vaccinated mouse and human patient serum. RESULTS: MST analysis of fluorescently tagged mAb08 binding to cocaine reveals an approximately 15 fold decrease in its equilibrium dissociation constant in 20–50% human serum compared with that in saline buffer. A similar trend was also found using enriched polyclonal antibodies purified from vaccinated mice and patient serum, for which we have used fluorescently tagged bovine serum albumin conjugated to succinyl norcocaine (BSA-SNC). This conjugate closely mimics both cocaine and the hapten used to raise these antibodies. The ITC data also revealed that cocaine has a moderate affinity of about 2 µM to 20% human serum and very little interaction with human serum albumin or nonspecific human IgG at that concentration range. In a SPR inhibition experiment, the binding of mAb08 to immobilized BSA-SNC was inhibited by cocaine and benzoylecgonine in a highly competitive manner, whereas the purified polyclonal antibodies from vaccinated humans and mice, revealed preferential selectivity to pharmacologically active cocaine but not to the inactive metabolite benzoylecgonine. We have also developed a simple binding model to simulate the challenges associated with cocaine immunotherapy using the variable quantitative and kinetic properties of the antibodies. CONCLUSIONS: High sensitivity calorimetric determination of antibody binding to cocaine and its metabolites provide valuable information for characterization of their interactions and thermodynamic properties. In addition MST measurements of antibody affinity in the presence of biological fluids will provide a better opportunity to make reliable decisions and facilitate the design of cocaine vaccines and immunization conditions. The methods should be more widely adopted in characterization of antibody complexes.
format Online
Article
Text
id pubmed-3409241
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34092412012-08-02 Probing Cocaine-Antibody Interactions in Buffer and Human Serum Ramakrishnan, Muthu Alves De Melo, Fernando Kinsey, Berma M. Ladbury, John E. Kosten, Thomas R. Orson, Frank M. PLoS One Research Article BACKGROUND: Despite progress in cocaine immunotherapy, the kinetic and thermodynamic properties of antibodies which bind to cocaine and its metabolites are not well understood. It is also not clear how the interactions between them differ in a complex matrix such as the serum present in the human body. In the present study, we have used microscale thermophoresis (MST), isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) we have evaluated the affinity properties of a representative mouse monoclonal (mAb08) as well as those of polyclonal antibodies purified from vaccinated mouse and human patient serum. RESULTS: MST analysis of fluorescently tagged mAb08 binding to cocaine reveals an approximately 15 fold decrease in its equilibrium dissociation constant in 20–50% human serum compared with that in saline buffer. A similar trend was also found using enriched polyclonal antibodies purified from vaccinated mice and patient serum, for which we have used fluorescently tagged bovine serum albumin conjugated to succinyl norcocaine (BSA-SNC). This conjugate closely mimics both cocaine and the hapten used to raise these antibodies. The ITC data also revealed that cocaine has a moderate affinity of about 2 µM to 20% human serum and very little interaction with human serum albumin or nonspecific human IgG at that concentration range. In a SPR inhibition experiment, the binding of mAb08 to immobilized BSA-SNC was inhibited by cocaine and benzoylecgonine in a highly competitive manner, whereas the purified polyclonal antibodies from vaccinated humans and mice, revealed preferential selectivity to pharmacologically active cocaine but not to the inactive metabolite benzoylecgonine. We have also developed a simple binding model to simulate the challenges associated with cocaine immunotherapy using the variable quantitative and kinetic properties of the antibodies. CONCLUSIONS: High sensitivity calorimetric determination of antibody binding to cocaine and its metabolites provide valuable information for characterization of their interactions and thermodynamic properties. In addition MST measurements of antibody affinity in the presence of biological fluids will provide a better opportunity to make reliable decisions and facilitate the design of cocaine vaccines and immunization conditions. The methods should be more widely adopted in characterization of antibody complexes. Public Library of Science 2012-07-10 /pmc/articles/PMC3409241/ /pubmed/22859949 http://dx.doi.org/10.1371/journal.pone.0040518 Text en This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Ramakrishnan, Muthu
Alves De Melo, Fernando
Kinsey, Berma M.
Ladbury, John E.
Kosten, Thomas R.
Orson, Frank M.
Probing Cocaine-Antibody Interactions in Buffer and Human Serum
title Probing Cocaine-Antibody Interactions in Buffer and Human Serum
title_full Probing Cocaine-Antibody Interactions in Buffer and Human Serum
title_fullStr Probing Cocaine-Antibody Interactions in Buffer and Human Serum
title_full_unstemmed Probing Cocaine-Antibody Interactions in Buffer and Human Serum
title_short Probing Cocaine-Antibody Interactions in Buffer and Human Serum
title_sort probing cocaine-antibody interactions in buffer and human serum
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409241/
https://www.ncbi.nlm.nih.gov/pubmed/22859949
http://dx.doi.org/10.1371/journal.pone.0040518
work_keys_str_mv AT ramakrishnanmuthu probingcocaineantibodyinteractionsinbufferandhumanserum
AT alvesdemelofernando probingcocaineantibodyinteractionsinbufferandhumanserum
AT kinseybermam probingcocaineantibodyinteractionsinbufferandhumanserum
AT ladburyjohne probingcocaineantibodyinteractionsinbufferandhumanserum
AT kostenthomasr probingcocaineantibodyinteractionsinbufferandhumanserum
AT orsonfrankm probingcocaineantibodyinteractionsinbufferandhumanserum